Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brachyury (TBXT) is a transcription factor essential for notochord and posterior mesoderm formation during embryonic development. It is a key biomarker for chordoma, a rare cancer derived from notochordal remnants, and is implicated in epithelial-to-mesenchymal transition and tumor metastasis in other cancers. It is considered a lineage-survival oncogene in chordoma and a potential therapeutic target.
Directly regulates gene expression by binding to DNA; induces or represses transcription of target genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brachyury transcription factor (TBXT).